tiprankstipranks
Trending News
More News >
Roche Holding AG (GB:0QOK)
LSE:0QOK
UK Market

Roche Holding AG (0QOK) Share Forecast & Price Target

Compare
32 Followers
See the Price Targets and Ratings of:

0QOK Analyst Ratings

Hold
12Ratings
Hold
5 Buy
4 Hold
3 Sell
Based on 12 analysts giving stock ratings to
Roche
Holding AG
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0QOK Stock 12 Month Forecast

Average Price Target

CHF302.01
▼(-8.39% Downside)
Based on 12 Wall Street analysts offering 12 month price targets for Roche Holding AG in the last 3 months. The average price target is CHF302.01 with a high forecast of CHF356.25 and a low forecast of CHF230.16. The average price target represents a -8.39% change from the last price of CHF329.66.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"229":"CHF229","261":"CHF261","293":"CHF293","325":"CHF325","357":"CHF357"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":356.25293514829406,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF356.25</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":302.0125744583,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF302.01</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":230.1634131576057,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF230.16</span>\n  </div></div>","useHTML":true}}],"tickPositions":[229,261,293,325,357],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,308.645,312.30714885756106,315.96929771512214,319.6314465726832,323.2935954302443,326.9557442878054,330.61789314536645,334.2800420029276,337.94219086048867,341.60433971804974,345.2664885756108,348.9286374331719,352.590786290733,{"y":356.25293514829406,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,308.645,308.1348134198692,307.6246268397384,307.11444025960765,306.6042536794769,306.09406709934615,305.58388051921537,305.0736939390846,304.5635073589538,304.05332077882304,303.5431341986923,303.03294761856154,302.52276103843076,{"y":302.0125744583,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,308.645,302.60795485827737,296.5709097165547,290.5338645748321,284.4968194331094,278.4597742913868,272.4227291496642,266.3856840079415,260.3486388662189,254.31159372449625,248.2745485827736,242.237503441051,236.20045829932832,{"y":230.1634131576057,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":247.325,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":247.319,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 15</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":279.94,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 19</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":288.31,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 18</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":292.587,"date":1743465600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 18</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":270.128,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":265.7,"date":1748736000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 15</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":258.651,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":258.028,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":259.632,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":280.254,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":258.861,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 20</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":308.645,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 17</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetCHF356.25Average Price TargetCHF302.01Lowest Price TargetCHF230.16
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on GB:0QOK
J.P. Morgan
J.P. Morgan
Hold
Reiterated
12/23/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and Annexon Biosciences (NASDAQ: ANNX)
Berenberg Bank Analyst forecast on GB:0QOK
Berenberg Bank
Berenberg Bank
CHF300CHF320
Hold
-2.93%
Downside
Reiterated
12/18/25
Berenberg Bank Reaffirms Their Hold Rating on Roche Holding AG (RHHVF)
Deutsche Bank  Analyst forecast on GB:0QOK
Deutsche Bank
Deutsche Bank
CHF325
Hold
-1.41%
Downside
Reiterated
12/12/25
Deutsche Bank Sticks to Their Hold Rating for Roche Holding AG (RHHVF)
UBS
CHF314CHF356
Buy
7.99%
Upside
Reiterated
12/11/25
UBS Reaffirms Their Buy Rating on Roche Holding AG (RHHVF)
Jefferies
CHF230
Sell
-30.23%
Downside
Reiterated
12/11/25
Jefferies Keeps Their Sell Rating on Roche Holding AG (RHHVF)
Goldman Sachs Analyst forecast on GB:0QOK
Goldman Sachs
Goldman Sachs
CHF260
Sell
-21.13%
Downside
Reiterated
12/11/25
Goldman Sachs Sticks to Its Sell Rating for Roche Holding AG (RHHVF)
Morgan Stanley Analyst forecast on GB:0QOK
Morgan Stanley
Morgan Stanley
CHF290
Sell
-12.03%
Downside
Reiterated
12/02/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Apogee Therapeutics (NASDAQ: APGE), Regeneron (NASDAQ: REGN) and Roche Holding AG (Other OTC: RHHVF)
Kepler Capital  Analyst forecast on GB:0QOK
Kepler Capital
Kepler Capital
CHF315
Buy
-4.45%
Downside
Reiterated
11/18/25
Kepler Capital Reaffirms Their Buy Rating on Roche Holding AG (RHHVF)
Bernstein Analyst forecast on GB:0QOK
Bernstein
Bernstein
CHF320CHF327
Buy
-0.81%
Downside
Reiterated
10/27/25
Roche Holding AG (RHHVF) Gets a Buy from Bernstein
Barclays Analyst forecast on GB:0QOK
Barclays
Barclays
CHF275
Hold
-16.58%
Downside
Reiterated
10/24/25
Barclays Sticks to Their Hold Rating for Roche Holding AG (RHHVF)
DZ BANK AG Analyst forecast on GB:0QOK
DZ BANK AG
DZ BANK AG
Buy
Reiterated
10/23/25
DZ BANK AG Keeps Their Buy Rating on Roche Holding AG (RHHVF)
HSBC
CHF285CHF320
Buy
-2.93%
Downside
Upgraded
10/01/25
HSBC upgrades Roche Holding AG (RHHVF) to a Buy
Exane BNP Paribas Analyst forecast on GB:0QOK
Exane BNP Paribas
Exane BNP Paribas
CHF300
Buy
-9.00%
Downside
Initiated
04/16/25
BNP Paribas Exane Starts Roche Holding (ROG:SW) (RHHBY) at OutperformBNP Paribas Exane analyst Peter Verdult initiates coverage on Roche Holding (ROG:SW) (OTC: RHHBY) with a Outperform rating and a price target of CHF300.00.
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on GB:0QOK
J.P. Morgan
J.P. Morgan
Hold
Reiterated
12/23/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and Annexon Biosciences (NASDAQ: ANNX)
Berenberg Bank Analyst forecast on GB:0QOK
Berenberg Bank
Berenberg Bank
CHF300CHF320
Hold
-2.93%
Downside
Reiterated
12/18/25
Berenberg Bank Reaffirms Their Hold Rating on Roche Holding AG (RHHVF)
Deutsche Bank  Analyst forecast on GB:0QOK
Deutsche Bank
Deutsche Bank
CHF325
Hold
-1.41%
Downside
Reiterated
12/12/25
Deutsche Bank Sticks to Their Hold Rating for Roche Holding AG (RHHVF)
UBS
CHF314CHF356
Buy
7.99%
Upside
Reiterated
12/11/25
UBS Reaffirms Their Buy Rating on Roche Holding AG (RHHVF)
Jefferies
CHF230
Sell
-30.23%
Downside
Reiterated
12/11/25
Jefferies Keeps Their Sell Rating on Roche Holding AG (RHHVF)
Goldman Sachs Analyst forecast on GB:0QOK
Goldman Sachs
Goldman Sachs
CHF260
Sell
-21.13%
Downside
Reiterated
12/11/25
Goldman Sachs Sticks to Its Sell Rating for Roche Holding AG (RHHVF)
Morgan Stanley Analyst forecast on GB:0QOK
Morgan Stanley
Morgan Stanley
CHF290
Sell
-12.03%
Downside
Reiterated
12/02/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Apogee Therapeutics (NASDAQ: APGE), Regeneron (NASDAQ: REGN) and Roche Holding AG (Other OTC: RHHVF)
Kepler Capital  Analyst forecast on GB:0QOK
Kepler Capital
Kepler Capital
CHF315
Buy
-4.45%
Downside
Reiterated
11/18/25
Kepler Capital Reaffirms Their Buy Rating on Roche Holding AG (RHHVF)
Bernstein Analyst forecast on GB:0QOK
Bernstein
Bernstein
CHF320CHF327
Buy
-0.81%
Downside
Reiterated
10/27/25
Roche Holding AG (RHHVF) Gets a Buy from Bernstein
Barclays Analyst forecast on GB:0QOK
Barclays
Barclays
CHF275
Hold
-16.58%
Downside
Reiterated
10/24/25
Barclays Sticks to Their Hold Rating for Roche Holding AG (RHHVF)
DZ BANK AG Analyst forecast on GB:0QOK
DZ BANK AG
DZ BANK AG
Buy
Reiterated
10/23/25
DZ BANK AG Keeps Their Buy Rating on Roche Holding AG (RHHVF)
HSBC
CHF285CHF320
Buy
-2.93%
Downside
Upgraded
10/01/25
HSBC upgrades Roche Holding AG (RHHVF) to a Buy
Exane BNP Paribas Analyst forecast on GB:0QOK
Exane BNP Paribas
Exane BNP Paribas
CHF300
Buy
-9.00%
Downside
Initiated
04/16/25
BNP Paribas Exane Starts Roche Holding (ROG:SW) (RHHBY) at OutperformBNP Paribas Exane analyst Peter Verdult initiates coverage on Roche Holding (ROG:SW) (OTC: RHHBY) with a Outperform rating and a price target of CHF300.00.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Roche Holding AG

1 Month
xxx
Success Rate
7/10 ratings generated profit
70%
Average Return
+3.48%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 70.00% of your transactions generating a profit, with an average return of +3.48% per trade.
3 Months
xxx
Success Rate
14/16 ratings generated profit
88%
Average Return
+8.97%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 87.50% of your transactions generating a profit, with an average return of +8.97% per trade.
1 Year
Success Rate
10/10 ratings generated profit
100%
Average Return
+25.43%
reiterated a buy rating 17 days ago
Copying Matthew Weston's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +25.43% per trade.
2 Years
xxx
Success Rate
16/16 ratings generated profit
100%
Average Return
+37.24%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +37.24% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0QOK Analyst Recommendation Trends

Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
0
0
0
0
0
Buy
13
15
14
15
12
Hold
8
9
9
10
13
Sell
14
16
16
20
17
Strong Sell
0
0
0
0
0
total
35
40
39
45
42
In the current month, 0QOK has received 12 Buy Ratings, 13 Hold Ratings, and 17 Sell Ratings. 0QOK average Analyst price target in the past 3 months is 302.01.
Each month's total comprises the sum of three months' worth of ratings.

0QOK Financial Forecast

0QOK Earnings Forecast

Next quarter’s earnings estimate for 0QOK is CHF8.55 with a range of CHF8.16 to CHF8.99. The previous quarter’s EPS was CHF11.08. 0QOK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year 0QOK has Performed in-line its overall industry.
Next quarter’s earnings estimate for 0QOK is CHF8.55 with a range of CHF8.16 to CHF8.99. The previous quarter’s EPS was CHF11.08. 0QOK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year 0QOK has Performed in-line its overall industry.

0QOK Sales Forecast

Next quarter’s sales forecast for 0QOK is CHF15.55B with a range of CHF14.96B to CHF16.13B. The previous quarter’s sales results were CHF30.94B. 0QOK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year 0QOK has Performed in-line its overall industry.
Next quarter’s sales forecast for 0QOK is CHF15.55B with a range of CHF14.96B to CHF16.13B. The previous quarter’s sales results were CHF30.94B. 0QOK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year 0QOK has Performed in-line its overall industry.

0QOK Stock Forecast FAQ

What is GB:0QOK’s average 12-month price target, according to analysts?
Based on analyst ratings, Roche Holding AG’s 12-month average price target is 302.01.
    What is GB:0QOK’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for GB:0QOK, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Roche Holding AG a Buy, Sell or Hold?
        Roche Holding AG has a consensus rating of Hold, which is based on 5 buy ratings, 4 hold ratings and 3 sell ratings.
          What is Roche Holding AG’s share price target?
          The average share price target for Roche Holding AG is 302.01. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF356.25 ,and the lowest forecast is CHF230.16. The average share price target represents -8.39% Decrease from the current price of CHF329.66.
            What do analysts say about Roche Holding AG?
            Roche Holding AG’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.
              How can I buy shares of Roche Holding AG?
              To buy shares of GB:0QOK, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.